The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지
DOI QR코드

DOI QR Code

Analysis of Herbal Medicine in the Clinical Guidelines of Korea and China for COVID-19

한국과 중국의 코로나-19 진료지침의 한약에 대한 비교분석 및 고찰

  • Seung-Bo Yang (Dept. of Korean Internal Medicine, College of Korean Medicine, Gachon University) ;
  • Aram Jeong (Dept. of Pediatrics, College of Korean Medicine, Gachon University)
  • 양승보 (가천대학교 한의과대학 한방내과교실) ;
  • 정아람 (가천대학교 한의과대학 소아과학교실)
  • Received : 2023.05.31
  • Accepted : 2023.06.27
  • Published : 2023.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

COVID-19 is an acute infectious disease caused by SARS-CoV-2 that has infected more than 700 million people around the world and left many deaths. In Korea and China, Korean medicine and Traditional Chinese Medicine were used to treat COVID-19, and the key element between them was herbal medicine. Clinical guidelines for herbal medicine have been published in Korea and China. In this review, the Korean and Chinese guidelines were compared and analyzed. This review was based on the latest revised clinical guidelines. The Korean guidelines covered all three guidelines published by The Association of Korean Medicine and The KM Professor Council of Internal Medicine of the Respiratory System. The Chinese guideline was published by the China National Health Commission. Based on research trends, a comprehensive comparison was made of the suggested prescriptions for each severity of COVID-19. It is expected that this review will be used as a reference for the treatment of COVID-19 or new infectious diseases in the future.

Keywords

Acknowledgement

이 성과는 정부(과학기술정보통신부)의 재원으로 한국연구재단의 지원을 받아 수행된 연구임 (No. 2022R1G1A1003601).

References

  1. Wang C, Horby PW, Hayden FG, Gao, GF. A novel coronavirus outbreak of global health concern. The lancet 2020;395(10223):470-3. https://doi.org/10.1016/S0140-6736(20)30185-9
  2. World Health Organization. Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic. Swiss: World Health Organization; 2023. (https://www.who.int/news/item/05-05-2023-statement-onthe-fifteenth-meeting-of-the-international-healthregulations-(2005)-emergency-committee-regardingthe-coronavirus-disease-(covid-19)-pandemic)
  3. World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Geneva: World Health Organization; 2023. (https://covid19.who.int/)
  4. Korea Disease Control and Prevention Agency. 질병관리청 코로나바이러스감염증-19. Cheongju: Korea Disease Control and Prevention Agency; 2023. (https://ncov.kdca.go.kr/)
  5. National Evidence-based Healthcare Collaborating Agency, Korean Academy of Medical Sciences. 코로나19 환자 치료를 위한 임상진료지침. National Evidence-based Healthcare Collaborating Agency, Korean Academy of Medical Sciences; 2022.
  6. Wang R, Yang S, Xie C, Shen Q, Li M, Lei X, et al, Huang M. Clinical observation of Qingfeipaidu Decoction in the treatment of COVID-19. Pharmacology and Clinics of Chinese Materia Medica 2020;36(1):13-8.
  7. Hu K, Guan WJ, Bi Y, Zhang W, Li L, Zhang B, et al. Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial. Phytomedicine 2021;85:153242.
  8. Lin TPH, Lau EMC, Wan KH, Zhong L, Leung E, Ko CN, et al. Initial observations of Jinhua Qinggan Granules, a Chinese medicine, in the mitigation of hospitalization and mortality in high-risk elderly with COVID-19 infection: A retrospective study in an old age home in Hong Kong. Front Med (Lausanne) 2022;9:948149.
  9. Zhu XB, Guo M, Zhang ZH, Sun LH, Liu L, Zhou LJ, et al. Chinese herbal injections for coronavirus disease 2019 (COVID-19): A narrative review. Integrative Medicine Research 2021;10(4):100778.
  10. National Health Commission of the People's Republic of China. Commission, C. N. H., 新型冠状病毒感染诊疗方案(试行第十版). (10). Beijing: National Health Commission of the People's Republic of China; 2023. (http://www.nhc.gov.cn/xcs/zhengcwj/202301/32de5b2ff9bf4eaa88e75bdf7223a65a.shtml)
  11. The KM Professor Council of Internal Medicine of the Respiratory System. 코로나바이러스감염증-19 한의진료지침. 2.1판. The KM Professor Council of Internal Medicine of the Respiratory System; 2020.
  12. The Association of Korean Medicine. 코로나19 한의진료지침 권고안. 2판. The Association of Korean Medicine; 2020.
  13. Ang L, Lee HW, Choi JY, Zhang J, Lee MS. Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines. Integr Med Res 2020;9(2):100407.
  14. Kim DS, Chu H, Min BK, Moon Y, Park S, Kim K, et al. Telemedicine Center of Korean Medicine for treating patients with COVID-19: a retrospective analysis. Integr Med Res 2020;9(3):100492.
  15. Kwon S, Lee W, Jin C, Jang I, Jung WS, Moon SK, et al. Could herbal medicine (Soshihotang) be a new treatment option for COVID-19?: a narrative review. Integr Med Res 2020;9(3):100480.
  16. Kang BH, Choi YK, Jeon CY, Yang SB. The Effects of Qingfei Paidu Decoction on Coronavirus Disease-19: A Narrative Review. The Journal of Internal Korean Medicine 2020;41(3):424-33. https://doi.org/10.22246/jikm.2020.41.3.424
  17. Zhang L, Ma Y, Shi N, Tong L, Liu S, Ji X, et al. Effect of Qingfei Paidu decoction combined with Western medicine treatments for COVID-19: A systematic review and meta-analysis. Phytomedicine 2022;102:154166.
  18. Wu Y, Xu L, Cao G, Min L, Dong T. Effect and Mechanism of Qingfei Paidu Decoction in the Management of Pulmonary Fibrosis and COVID-19. Am J Chin Med 2022;50(1):33-51. https://doi.org/10.1142/S0192415X22500021
  19. Li J, Zhang K, Bao J, Yang J, Wu C. Potential mechanism of action of Jing Fang Bai Du San in the treatment of COVID-19 using docking and network pharmacology. Int J Med Sci 2022;19(2):213-24. https://doi.org/10.7150/ijms.67116
  20. Wu J, Tang F, Zhang XQ, Fu ZL, Fu S. Application of Jiawei Maxing Shigan Tang in the treatment of COVID-19: An observational study. Front Med (Lausanne) 2022;9:1028171.
  21. Si X, Ma X, Wang Y, Li Y, Liu L, Yang Y, et al. Efficacy and safety of Jinhua Qinggan granules in the treatment of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Medicine (Baltimore) 2023;102(15):e33545.
  22. Sun XH, Zhang S, Yang Z, Chen ZL, Yue SJ, Zhang S, et al. Efficacy and Safety of Lianhua Qingwen for Patients with COVID-19: A Systematic Review and Meta-Analysis. Chin J Integr Med 2022;28(7):650-60. https://doi.org/10.1007/s11655-022-3578-8
  23. Xiong WZ, Wang G, Du J, Ai W. Efficacy of herbal medicine (Xuanfei Baidu decoction) combined with conventional drug in treating COVID-19:A pilot randomized clinical trial. Integr Med Res 2020;9(3):100489.
  24. Liu J, Yang W, Liu Y, Lu C, Ruan L, Zhao C, et al. Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trial. Phytomedicine 2021;91:153671.
  25. Liu S, Yao C, Xie J, Liu H, Wang H, Lin Z, et al. Effect of an Herbal-Based Injection on 28-Day Mortality in Patients With Sepsis: The EXIT-SEP Randomized Clinical Trial. JAMA Intern Med 2023:e230780.
  26. Li C, Wang P, Zhang L, Li M, Lei X, Liu S, et al. Efficacy and safety of Xuebijing injection (a Chinese patent) for sepsis: A meta-analysis of randomized controlled trials. J Ethnopharmacol 2018;224:512-21. https://doi.org/10.1016/j.jep.2018.05.043
  27. Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. bmj 2021;374:n1648.
  28. Li L, Gou CY, Li XM, Song WY, Wang XJ, Li HY, et al. Effects of Chinese Medicine on Symptoms, Syndrome Evolution, and Lung Inflammation Absorption in COVID-19 Convalescent Patients during 84-Day Follow-up after Hospital Discharge: A Prospective Cohort and Nested Case-Control Study. Chin J Integr Med 2021; 27(4):245-51. https://doi.org/10.1007/s11655-021-3328-3
  29. Liu X, Zhang M, He L, Li Y. Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS). Cochrane Database Syst Rev 2012;10(10):Cd004882.
  30. Kim SH. Discussion on Classical Text-based Evidence in Guidelines for the Traditional Chinese Medical Treatment of COVID-19. J Korean Med Classics 2022;35(4):115-25. https://doi.org/10.3346/jkms.2022.37.e115
  31. Zhang L, Yu J, Zhou Y, Shen M, Sun L. Becoming a Faithful Defender: Traditional Chinese Medicine against Coronavirus Disease 2019 (COVID-19). Am J Chin Med 2020;48(4):763-77. https://doi.org/10.1142/S0192415X2050038X